Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.

Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF; Lancet. 2015; 386(9992):433-443

Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model.

Gassner, FJ; Zaborsky, N; Catakovic, K; Rebhandl, S; Huemer, M; Egle, A; Hartmann, TN; Greil, R; Geisberger, R; Br J Haematol. 2015; 170(4):515-522

AIDing cancer treatment: Reducing AID activity via HSP90 inhibition.

Rebhandl, S; Geisberger, R; Eur J Immunol. 2015; 45(8): 2208-2211.

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.

Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M; Jakesz, R; Ferree, S; Cowens, JW; Nielsen, T; Schaper, C; Fesl, C; Cuzick, J; Ann Oncol. 2015; 26(8):1685-1691

Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.

Merkel, O; Hamacher, F; Griessl, R; Grabner, L; Schiefer, AI; Prutsch, N; Baer, C; Egger, G; Schlederer, M; Krenn, PW; Hartmann, TN; Simonitsch-Klupp, I; Plass, C; Staber, PB; Moriggl, R; Turner, SD; Greil, R; Kenner, L; J Pathol. 2015; 236(4):445-456

[Therapie des Patienten mit Radioiod-refraktärem, differenziertem Schilddrüsenkarzinom. Ein Konsensusstatement].

Lindner, C; Dierneder, J; Pall, G; Pirich, C; Hoffmann, M; Raderer, M; Becherer, A; Niederle, B; Lipp, R; Lind, P; Gallowitsch, H; Romeder, F; Virgolini, I; Nuklearmedizin. 2015; 54(3): 125-130.

Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study

Leierer, G; Grabmeier-Pfistershammer, K; Steuer, A; Geit, M; Sarcletti, M; Haas, B; Kanatschnig, M; Rappold, M; Zangerle, R; Ledergerber, B; Taylor, N PLOS ONE. 2015; 10(11):

Digging deep into „dirty“ drugs – modulation of the methylation machinery.

Pleyer, L; Greil, R; Drug Metab Rev. 2015; 47(2):252-279

AID/APOBEC deaminases and cancer.

Rebhandl, S; Huemer, M; Greil, R; Geisberger, R; Oncoscience. 2015; 2(4):320-333

Renaissance eines alten Bekannten – Bedeutung des Androgenrezeptors beim Mammakarzinom

Rinnerthaler, G; Wiener klinisches Magazin. 2015; 18(6):